Anti-Anxiety Drug Market Size Report, Industry Analysis, Share, Growth, 2030
Anti-Anxiety Drug Market By Drug Class (Selective Serotonin Reuptake Inhibitors (SSRIs), Benzodiazepines, Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and Beta-Blockers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/Drug Stores, and Online Pharmacies) and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 - 2030
Category: Pharmaceutical Report Format : PDF
Pages: 211 Report Code: ZMR-7953
Published Date: Jan-2024 Status : Published
| Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 15.23 Billion | USD 21.22 Billion | 4.23% | 2022 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Anti-Anxiety Drug Market, (2023 - 2030) (USD Billion)
- 2.2 Global Anti-Anxiety Drug Market : snapshot
- Chapter 3. Global Anti-Anxiety Drug Market - Industry Analysis
- 3.1 Anti-Anxiety Drug Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Escalating prevalence of anxiety disorders worldwide is propelling market growth
- 3.3 Market Restraints
- 3.3.1. Potential for side effects and the risk of dependency associated with certain classes of medications may hinder market growth.
- 3.4 Market Opportunities
- 3.4.1. Increasing focus on mental health awareness and the integration of novel therapeutic approaches to provide growth opportunities
- 3.5 Market Challenges
- 3.5.1. Existing industry inertia and establishing widespread acceptance to challenge market growth
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Class
- 3.7.2 Market attractiveness analysis By Distribution Channel
- Chapter 4. Global Anti-Anxiety Drug Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Anti-Anxiety Drug Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Anti-Anxiety Drug Market - Drug Class Analysis
- 5.1 Global Anti-Anxiety Drug Market overview: By Drug Class
- 5.1.1 Global Anti-Anxiety Drug Market share, By Drug Class, 2022 and 2030
- 5.2 Selective Serotonin Reuptake Inhibitors (SSRIs)
- 5.2.1 Global Anti-Anxiety Drug Market by Selective Serotonin Reuptake Inhibitors (SSRIs), 2023 - 2030 (USD Billion)
- 5.3 Benzodiazepines
- 5.3.1 Global Anti-Anxiety Drug Market by Benzodiazepines, 2023 - 2030 (USD Billion)
- 5.4 Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- 5.4.1 Global Anti-Anxiety Drug Market by Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), 2023 - 2030 (USD Billion)
- 5.5 Beta Blockers
- 5.5.1 Global Anti-Anxiety Drug Market by Beta Blockers, 2023 - 2030 (USD Billion)
- 5.1 Global Anti-Anxiety Drug Market overview: By Drug Class
- Chapter 6. Global Anti-Anxiety Drug Market - Distribution Channel Analysis
- 6.1 Global Anti-Anxiety Drug Market overview: By Distribution Channel
- 6.1.1 Global Anti-Anxiety Drug Market share, By Distribution Channel, 2022 and 2030
- 6.2 Hospital Pharmacies
- 6.2.1 Global Anti-Anxiety Drug Market by Hospital Pharmacies, 2023 - 2030 (USD Billion)
- 6.3 Retail Pharmacies/Drug Stores
- 6.3.1 Global Anti-Anxiety Drug Market by Retail Pharmacies/Drug Stores, 2023 - 2030 (USD Billion)
- 6.4 Online Pharmacies
- 6.4.1 Global Anti-Anxiety Drug Market by Online Pharmacies, 2023 - 2030 (USD Billion)
- 6.1 Global Anti-Anxiety Drug Market overview: By Distribution Channel
- Chapter 7. Anti-Anxiety Drug Market - Regional Analysis
- 7.1 Global Anti-Anxiety Drug Market Regional Overview
- 7.2 Global Anti-Anxiety Drug Market Share, by Region, 2022 & 2030 (USD Billion)
- 7.3. North America
- 7.3.1 North America Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.3.1.1 North America Anti-Anxiety Drug Market, by Country, 2023 - 2030 (USD Billion)
- 7.3.1 North America Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.4 North America Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030
- 7.4.1 North America Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030 (USD Billion)
- 7.5 North America Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030
- 7.5.1 North America Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.4.2.1 Europe Anti-Anxiety Drug Market, by Country, 2023 - 2030 (USD Billion)
- 7.4.2 Europe Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.4 Europe Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030
- 7.4.1 Europe Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030 (USD Billion)
- 7.5 Europe Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030
- 7.5.1 Europe Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.5.3.1 Asia Pacific Anti-Anxiety Drug Market, by Country, 2023 - 2030 (USD Billion)
- 7.5.3 Asia Pacific Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.4 Asia Pacific Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030
- 7.4.1 Asia Pacific Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030 (USD Billion)
- 7.5 Asia Pacific Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030
- 7.5.1 Asia Pacific Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.6.4.1 Latin America Anti-Anxiety Drug Market, by Country, 2023 - 2030 (USD Billion)
- 7.6.4 Latin America Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.4 Latin America Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030
- 7.4.1 Latin America Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030 (USD Billion)
- 7.5 Latin America Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030
- 7.5.1 Latin America Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Anti-Anxiety Drug Market, by Country, 2023 - 2030 (USD Billion)
- 7.7.5 The Middle-East and Africa Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 7.4 The Middle-East and Africa Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030
- 7.4.1 The Middle-East and Africa Anti-Anxiety Drug Market, by Drug Class, 2023 - 2030 (USD Billion)
- 7.5 The Middle-East and Africa Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030
- 7.5.1 The Middle-East and Africa Anti-Anxiety Drug Market, by Distribution Channel, 2023 - 2030 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Pfizer Inc.
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Eli Lilly and Company
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 GlaxoSmithKline plc
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Johnson & Johnson
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 AstraZeneca plc
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Roche Holding AG
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Forest Laboratories (a subsidiary of Allergan
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 now part of AbbVie)
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Bristol Myers Squibb Company
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Sanofi S.A.
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Lundbeck A/S.
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 and others.
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.1 Pfizer Inc.
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Anti-Anxiety Drug Market attractiveness, By Drug Class
- 6. Global Anti-Anxiety Drug Market attractiveness, By Distribution Channel
- 7. Global Anti-Anxiety Drug Market share by Drug Class, 2023 and 2030 (USD Billion)
- 8. Global Anti-Anxiety Drug Market by Selective Serotonin Reuptake Inhibitors (SSRIs), 2023 - 2030 (USD Billion)
- 9. Global Anti-Anxiety Drug Market by Benzodiazepines, 2023 - 2030 (USD Billion)
- 10. Global Anti-Anxiety Drug Market by Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), 2023 - 2030 (USD Billion)
- 11. Global Anti-Anxiety Drug Market by Beta Blockers, 2023 - 2030 (USD Billion)
- 12. Global Anti-Anxiety Drug Market share by Distribution Channel, 2023 and 2030 (USD Billion)
- 13. Global Anti-Anxiety Drug Market by Hospital Pharmacies, 2023 - 2030 (USD Billion)
- 14. Global Anti-Anxiety Drug Market by Retail Pharmacies/Drug Stores, 2023 - 2030 (USD Billion)
- 15. Global Anti-Anxiety Drug Market by Online Pharmacies, 2023 - 2030 (USD Billion)
- 16. Global Anti-Anxiety Drug Market share, by Region, 2023 and 2030
- 17. North America Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 18. Europe Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 19. Asia Pacific Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 20. Latin America Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
- 21. The Middle-East and Africa Anti-Anxiety Drug Market, 2023 - 2030 (USD Billion)
Table Of Tables
- 1. Global Anti-Anxiety Drug Market: Snapshot
- 2. Drivers of the Anti-Anxiety Drug Market: impact analysis
- 3. North America Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 4. North America Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 5. U.S. Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 6. U.S. Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 7. Canada Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 8. Canada Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 9. Europe Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 10. Europe Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 11. Germany Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 12. Germany Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 13. France Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 14. France Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 15. U.K. Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 16. U.K. Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 17. Italy Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 18. Italy Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 19. Spain Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 20. Spain Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 21. Rest of Europe Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 22. Rest of Europe Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 23. Asia Pacific Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 24. Asia Pacific Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 25. China Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 26. China Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 27. Japan Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 28. Japan Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 29. India Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 30. India Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 31. South Korea Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 32. South Korea Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 33. South-East Asia Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 34. South-East Asia Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 35. Rest of Asia Pacific Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 36. Rest of Asia Pacific Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 37. Latin America Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 38. Latin America Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 39. Brazil Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 40. Brazil Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 41. Mexico Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 42. Mexico Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 43. Rest of Latin America Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 44. Rest of Latin America Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 45. The Middle-East and Africa Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 46. The Middle-East and Africa Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 47. GCC Countries Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 48. GCC Countries Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 49. South Africa Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 50. South Africa Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
- 51. Rest of Middle-East Africa Anti-Anxiety Drug Market revenue, By Drug Class, 2023 - 2030 (USD Billion)
- 52. Rest of Middle-East Africa Anti-Anxiety Drug Market revenue, By Distribution Channel, 2023 - 2030 (USD Billion)
Methodology
FrequentlyAsked Questions
Anti-anxiety drugs, often known as anxiolytics, are pharmaceuticals that work on the central nervous system to decrease anxiety symptoms. Benzodiazepines are a prevalent family of these drugs that increase the inhibitory neurotransmitter GABA, resulting in a calming effect.
The global anti-anxiety drug market cap may grow owing to the due to the due to growing prevalence of anxiety disorders and recent advancements in drug development
According to study, the global anti-anxiety drug market size was worth around USD 15.23 billion in 2022 and is predicted to grow to around USD 21.22 billion by 2030.
The CAGR value of the anti-anxiety drug market is expected to be around 4.23% during 2023-2030.
The global anti-anxiety drug market growth is expected to be driven by Asia Pacific. It is world's most profitable market pushed by a rising emphasis on intellectual wellness concerns and solid pharmaceutical sector growth, notably in nations like as China and India.
The global anti-anxiety drug market is led by players like Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca plc, Roche Holding AG, Forest Laboratories (a subsidiary of Allergan, now part of AbbVie), Bristol Myers Squibb Company, Sanofi S.A., and Lundbeck A/S.
The report analyzes the global anti-anxiety drug market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the anti-anxiety drug class industry.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed